119 related articles for article (PubMed ID: 16450942)
1. [Prognostic value of clinicopathologic factors in superficial bladder tumors: a retrospective analysis].
Rammeh-Rommani S; Zermani R; Zouari B; Sfaxi M; Chabchoub A; Farah F; Kourda N; Ayed M; Ben Jilani S
Tunis Med; 2005 Dec; 83(12):746-9. PubMed ID: 16450942
[TBL] [Abstract][Full Text] [Related]
2. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer.
Divrik RT; Sahin A; Altok M; Unlü N; Zorlu F
J Urol; 2007 Sep; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
Yang TB; Zeng FH; Sun ZQ
Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of prognostic factors in superficial bladder tumors].
Páez Borda A; Martín Osés E; de la Cal López M; Llorente Abarca C; Berenguer Sánchez A
Arch Esp Urol; 1997 Mar; 50(2):121-6. PubMed ID: 9206936
[TBL] [Abstract][Full Text] [Related]
5. Motility-related protein 1 (MRP-1/CD9) expression in urothelial bladder carcinoma and its relation to tumor recurrence and progression.
Mhawech P; Herrmann F; Coassin M; Guillou L; Iselin CE
Cancer; 2003 Oct; 98(8):1649-57. PubMed ID: 14534881
[TBL] [Abstract][Full Text] [Related]
6. [Superficial grade G2 tumors of the bladder: recurrence, progression, prognosis].
Sebe P; Lebret T; Molinie V; Herve JM; Yonneau L; Lugagne PM; Saporta F; Orsoni JL; Butreau M; Botto H
Prog Urol; 2003 Sep; 13(4):608-12. PubMed ID: 14650291
[TBL] [Abstract][Full Text] [Related]
7. Proliferative status is a risk index for recurrence in primary superficial (pTa/T1) low-grade urothelial bladder carcinoma.
Su JS; Arima K; Hasegawa M; Franco OE; Yanagawa M; Sugimura Y; Kawamura J
Hinyokika Kiyo; 2003 Nov; 49(11):649-58. PubMed ID: 14719452
[TBL] [Abstract][Full Text] [Related]
8. Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumors.
Palou J; Rodríguez-Rubio F; Millán F; Algaba F; Rodríguez-Faba O; Huguet J; Villavicencio H
Urology; 2009 Jun; 73(6):1313-7. PubMed ID: 19362341
[TBL] [Abstract][Full Text] [Related]
9. [The prognostic factors in T1 superficial bladder carcinoma. Our experience].
Moyano Calvo JL; Romero Díaz A; Ortíz Gamiz A; Sánchez Sánchez E; Blanco Palenciano E; Arribas Rodríguez JM; Castiñeiras Fernández J
Arch Esp Urol; 1999 Jun; 52(5):465-70. PubMed ID: 10427884
[TBL] [Abstract][Full Text] [Related]
10. [Mid-term results of a program for the monitoring of superficial bladder tumors].
Paez Borda A; Luján Galán M; Llanes González L; Gómez de Vicente JM; Berenguer Sánchez A
Arch Esp Urol; 1999 Apr; 52(3):229-34; discussion 234-5. PubMed ID: 10371738
[TBL] [Abstract][Full Text] [Related]
11. [Contribution of cell cycle and DNA content study by flow cytometry in the prognosis of superficial bladder cancer: Tunisian experience].
Bounemra-Benghanem A; Amri MA; Rammeh-Rommani S; Chebil M; Zermani R; Ben Jilani S; Jenhani F
Ann Biol Clin (Paris); 2007; 65(1):41-9. PubMed ID: 17264038
[TBL] [Abstract][Full Text] [Related]
12. Outcome of very large superficial bladder tumours: a 10-year experience.
Gupta SK; Parr NJ
Scand J Urol Nephrol; 2008; 42(3):243-8. PubMed ID: 18432531
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic value of the immunohistochemical expression of: Ki67, p53, PCNA and Bcl2 in the superficial tumors of the bladder].
Rammeh-Rommani S; Zermani R; Sfaxi M; Chabchoub A; Zouari B; Ayed M; Ben Jilani-Baltagi S
Tunis Med; 2007 Jun; 85(6):509-12. PubMed ID: 17644907
[TBL] [Abstract][Full Text] [Related]
14. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
[TBL] [Abstract][Full Text] [Related]
15. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
16. Predicting recurrence and progression in non-muscle-invasive bladder cancer using European organization of research and treatment of cancer risk tables.
Ather MH; Zaidi M
Urol J; 2009; 6(3):189-93. PubMed ID: 19711273
[TBL] [Abstract][Full Text] [Related]
17. [Expectant treatment of superficial bladder tumors: preliminary results].
Páez Borda A; de la Cal López MA; Llorente Abarca C; Acebal Lucia J; Herrero Payo A; Sánchez Sánchez E; Ruiz de la Roja JC; Berenguer Sánchez A
Actas Urol Esp; 1995 Apr; 19(4):288-93. PubMed ID: 8815653
[TBL] [Abstract][Full Text] [Related]
18. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Raman JD; Sosa RE; Vaughan ED; Scherr DS
Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic factors in superficial bladder carcinoma. Analysis of 250 cases].
Salinas Sánchez AS; Moreno Avilés J; García Hernández JA; Gómez Gómez GA; Martínez Pertusa P; Server Falgas G
Actas Urol Esp; 1989; 13(3):177-80. PubMed ID: 2763882
[TBL] [Abstract][Full Text] [Related]
20. Conservative management of low risk superficial bladder tumors.
Pruthi RS; Baldwin N; Bhalani V; Wallen EM
J Urol; 2008 Jan; 179(1):87-90; discussion 90. PubMed ID: 17997444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
